Teladoc Health, Inc. (TDOC) recently showcased data from two studies at the American Diabetes Association's 84th Scientific Sessions. These studies highlight Teladoc's predictive modeling capabilities in aiding members with type 2 diabetes to manage their blood sugar levels through its diabetes management program. Following the news, the stock gained 6.7% yesterday. Leveraging AI is helping the company with digital interventions, while keeping the human touch in member interactions, leading to better health ...